-

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Co-Diagnostics, Inc. (CODX) and Encourages Long-Term CODX Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Co-Diagnostics, Inc. (“Co-Diagnostics” or the Company) (NASDAQ: CODX) on behalf of the Company’s long-term investors. The investigation seeks to determine whether the members of Co-Diagnostics’ board of directors violated the securities laws and/or breached their fiduciary duties in connection with alleged corporate misconduct.

Recently a shareholder class action complaint was filed against Co-Diagnostics on behalf of certain investors who purchased shares of the Company’s common stock between April 30, 2020 and May 15, 2020. According to the complaint, during that time period Co-Diagnostics and certain of the Company’s senior executive officers “made continual, knowing, and willful misstatements about their main product, a Covid-19 diagnostic test marketed under the name ‘Logix Smart’, to pump up the price of Co-Diagnostics’ stock,” including claims that the Logix Smart test was 100% effective.

The complaint further alleges that the Company’s “officers and directors exercised low priced options and dumped their stock into the market without informing the investing public” about the true limitations of the Logix Smart test, and prior to the Company’s stock price declining in value.

Current Co-Diagnostics stockholders who purchased or acquired shares of the Company’s common stock prior to April 30, 2020 are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/co-diagnostics-inc/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation, and has helped recover in excess of $150 million on behalf of victimized investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com

Adrienne Bell, Esq.
abell@kaskelalaw.com

18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:CODX

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com

Adrienne Bell, Esq.
abell@kaskelalaw.com

18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

ATTENTION STIFEL BROKERAGE CUSTOMERS: Kaskela Law LLC Announces Class Action Lawsuit Filed Against Stifel Nicolaus & Co. Inc. and Encourages Brokerage Customers to Contact the Firm to Discuss Their Legal Rights and Options

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that a class action lawsuit has been filed against Stifel Nicolaus & Co., Inc. (“Stifel”) on behalf of certain Stifel customers who maintained brokerage accounts with automatic cash sweep programs. According to the complaint, “Stifel violated its fiduciary, contractual, and implied duties by underpaying its clients to enrich itself and its affiliates at its clients’ expense. Rather than pay clients a fair and reasonable rate of intere...

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating The Beauty Health Company (NASDAQ: SKIN) (“Beauty Health”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/case/the-beauty-health-company/ Since March 2024, shares of Beauty Health’s common stock have declined in value from a trading price of approximately $4.50 per share to a current trading price of below $1.75 per share, a decline of over 60% in value. The...

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of DHI Group, Inc. (NYSE: DHX) and Encourages Long-Term Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating DHI Group, Inc. (NYSE: DHX) (“DHI”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/case/dhi-group/ Since January 2023, shares of DHI’s common stock have declined in value from a trading price of over $6.00 per share to a current trading price of below $3.00 per share, a decline of over 50% in value. The investigation seeks to determine whether DHI and/or the...
Back to Newsroom